Search research articles
Contact Us
Filters
Showing results (81-90 of 126) with videos related to
Page
of 13
Sort By:
International Journal of Cancer
|
July 9, 1993
Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinoma
F Farace, E Angevin, B Escudier, et al.
European Journal of Immunology
|
July 1, 1993
Fine specificity of monoclonal antibodies directed at human T cell receptor variable regions: comparison with oligonucleotide-driven amplification for evaluation of V beta expression
A Diu, F Romagné, C Genevée, et al.
The Journal of Clinical Investigation
|
April 1, 1994
Direct evidence to support the immunosurveillance concept in a human regressive melanoma
A Mackensen, G Carcelain, S Viel, et al.
European Journal of Immunology
|
December 1, 1988
A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytes
F Triebel, F Faure, F Mami-Chouaib, et al.
International Journal of Cancer
|
July 17, 1997
In situ T-cell responses in a primary regressive melanoma and subsequent metastases: a comparative analysis
G Carcelain, N Rouas-Freiss, E Zorn, et al.
Journal of Autoimmunity
|
August 1, 1988
T cells expressing gamma delta chain receptors in rheumatoid arthritis
F M Brennan, M Londei, A M Jackson, et al.
Journal of Autoimmunity
|
December 1, 1993
In-situ preferential usage of V alpha 8 T-cell receptor gene segments in a patient with bullous pemphigoid
H Michalaki, S Roman-Roman, J F Nicolas, et al.
Molecular Immunology
|
November 1, 1990
Cloning and expression of a lymphocyte activation gene (LAG-1)
E Baixeras, S Roman-Roman, S Jitsukawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 1987
rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2
M H Ben Aribia, E Leroy, O Lantz, et al.
Clinical and Experimental Immunology
|
November 1, 1990
Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma
F Farace, C Mathiot, M Brandely, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 126) with videos related to
Sort By:
Page
of 13
International Journal of Cancer
|
July 9, 1993
Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinoma
F Farace, E Angevin, B Escudier, et al.
European Journal of Immunology
|
July 1, 1993
Fine specificity of monoclonal antibodies directed at human T cell receptor variable regions: comparison with oligonucleotide-driven amplification for evaluation of V beta expression
A Diu, F Romagné, C Genevée, et al.
The Journal of Clinical Investigation
|
April 1, 1994
Direct evidence to support the immunosurveillance concept in a human regressive melanoma
A Mackensen, G Carcelain, S Viel, et al.
European Journal of Immunology
|
December 1, 1988
A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytes
F Triebel, F Faure, F Mami-Chouaib, et al.
International Journal of Cancer
|
July 17, 1997
In situ T-cell responses in a primary regressive melanoma and subsequent metastases: a comparative analysis
G Carcelain, N Rouas-Freiss, E Zorn, et al.
Journal of Autoimmunity
|
August 1, 1988
T cells expressing gamma delta chain receptors in rheumatoid arthritis
F M Brennan, M Londei, A M Jackson, et al.
Journal of Autoimmunity
|
December 1, 1993
In-situ preferential usage of V alpha 8 T-cell receptor gene segments in a patient with bullous pemphigoid
H Michalaki, S Roman-Roman, J F Nicolas, et al.
Molecular Immunology
|
November 1, 1990
Cloning and expression of a lymphocyte activation gene (LAG-1)
E Baixeras, S Roman-Roman, S Jitsukawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
July 15, 1987
rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2
M H Ben Aribia, E Leroy, O Lantz, et al.
Clinical and Experimental Immunology
|
November 1, 1990
Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma
F Farace, C Mathiot, M Brandely, et al.
Page
of 13